[
  {
    "sentence": "44\n, \n45\n This process is induced via complicated interactions between genetic and environmental factors such as UV radiation, genetic mutations, oncogene activation, malignancy suppressor gene deactivation, and DNA repair process disorder (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "4\n, \n5\n, \n46\n, \n47\n, \n48\n, \n49\n, \n50\n, \n51\n\n\nFigure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The genomic changes induce impairments to the activation of fundamental signaling pathways, namely, the PI3K pathway and the RAS/rapidly accelerated fibrosarcoma (RAF)/mitogen‐activated protein kinase (MEK)/extracellular‐regulated kinase (ERK) signaling cascade, also known as the MAPK pathway (Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "86\n, \n87\n, \n88\n, \n89\n\n\nFigure 2.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "31\n, \n97\n, \n104\n, \n105\n Both CDK4 and CDKN2A participate in the regulation of the cell cycle and regulate the transition of tumor cells from the G1 to S phase and thus can cause uncontrolled proliferation (Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Currently, chemotherapy is considered a treatment of last resort for patients with resistance to more effective therapies (immunotherapies and targeted therapies) or in countries where access to new more‐effective drugs is limited\n3\n, \n63\n, \n108\n, \n114\n (Figure 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Moreover, the length of the linear hydrocarbon substituent at the C7 position of the A ring has a directly proportional effect on the antiproliferative activity (Figure 4).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "44\n, \n45\n This process is induced via complicated interactions between genetic and environmental factors such as UV radiation, genetic mutations, oncogene activation, malignancy suppressor gene deactivation, and DNA repair process disorder (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "4\n, \n5\n, \n46\n, \n47\n, \n48\n, \n49\n, \n50\n, \n51\n\n\nFigure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The genomic changes induce impairments to the activation of fundamental signaling pathways, namely, the PI3K pathway and the RAS/rapidly accelerated fibrosarcoma (RAF)/mitogen‐activated protein kinase (MEK)/extracellular‐regulated kinase (ERK) signaling cascade, also known as the MAPK pathway (Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "86\n, \n87\n, \n88\n, \n89\n\n\nFigure 2.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "31\n, \n97\n, \n104\n, \n105\n Both CDK4 and CDKN2A participate in the regulation of the cell cycle and regulate the transition of tumor cells from the G1 to S phase and thus can cause uncontrolled proliferation (Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Currently, chemotherapy is considered a treatment of last resort for patients with resistance to more effective therapies (immunotherapies and targeted therapies) or in countries where access to new more‐effective drugs is limited\n3\n, \n63\n, \n108\n, \n114\n (Figure 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Moreover, the length of the linear hydrocarbon substituent at the C7 position of the A ring has a directly proportional effect on the antiproliferative activity (Figure 4).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "44\n, \n45\n This process is induced via complicated interactions between genetic and environmental factors such as UV radiation, genetic mutations, oncogene activation, malignancy suppressor gene deactivation, and DNA repair process disorder (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "4\n, \n5\n, \n46\n, \n47\n, \n48\n, \n49\n, \n50\n, \n51\n\n\nFigure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The genomic changes induce impairments to the activation of fundamental signaling pathways, namely, the PI3K pathway and the RAS/rapidly accelerated fibrosarcoma (RAF)/mitogen‐activated protein kinase (MEK)/extracellular‐regulated kinase (ERK) signaling cascade, also known as the MAPK pathway (Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "86\n, \n87\n, \n88\n, \n89\n\n\nFigure 2.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "31\n, \n97\n, \n104\n, \n105\n Both CDK4 and CDKN2A participate in the regulation of the cell cycle and regulate the transition of tumor cells from the G1 to S phase and thus can cause uncontrolled proliferation (Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Currently, chemotherapy is considered a treatment of last resort for patients with resistance to more effective therapies (immunotherapies and targeted therapies) or in countries where access to new more‐effective drugs is limited\n3\n, \n63\n, \n108\n, \n114\n (Figure 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Moreover, the length of the linear hydrocarbon substituent at the C7 position of the A ring has a directly proportional effect on the antiproliferative activity (Figure 4).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "44\n, \n45\n This process is induced via complicated interactions between genetic and environmental factors such as UV radiation, genetic mutations, oncogene activation, malignancy suppressor gene deactivation, and DNA repair process disorder (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "4\n, \n5\n, \n46\n, \n47\n, \n48\n, \n49\n, \n50\n, \n51\n\n\nFigure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The genomic changes induce impairments to the activation of fundamental signaling pathways, namely, the PI3K pathway and the RAS/rapidly accelerated fibrosarcoma (RAF)/mitogen‐activated protein kinase (MEK)/extracellular‐regulated kinase (ERK) signaling cascade, also known as the MAPK pathway (Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "86\n, \n87\n, \n88\n, \n89\n\n\nFigure 2.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "31\n, \n97\n, \n104\n, \n105\n Both CDK4 and CDKN2A participate in the regulation of the cell cycle and regulate the transition of tumor cells from the G1 to S phase and thus can cause uncontrolled proliferation (Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Currently, chemotherapy is considered a treatment of last resort for patients with resistance to more effective therapies (immunotherapies and targeted therapies) or in countries where access to new more‐effective drugs is limited\n3\n, \n63\n, \n108\n, \n114\n (Figure 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Moreover, the length of the linear hydrocarbon substituent at the C7 position of the A ring has a directly proportional effect on the antiproliferative activity (Figure 4).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "44\n, \n45\n This process is induced via complicated interactions between genetic and environmental factors such as UV radiation, genetic mutations, oncogene activation, malignancy suppressor gene deactivation, and DNA repair process disorder (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "4\n, \n5\n, \n46\n, \n47\n, \n48\n, \n49\n, \n50\n, \n51\n\n\nFigure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The genomic changes induce impairments to the activation of fundamental signaling pathways, namely, the PI3K pathway and the RAS/rapidly accelerated fibrosarcoma (RAF)/mitogen‐activated protein kinase (MEK)/extracellular‐regulated kinase (ERK) signaling cascade, also known as the MAPK pathway (Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "86\n, \n87\n, \n88\n, \n89\n\n\nFigure 2.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "31\n, \n97\n, \n104\n, \n105\n Both CDK4 and CDKN2A participate in the regulation of the cell cycle and regulate the transition of tumor cells from the G1 to S phase and thus can cause uncontrolled proliferation (Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Currently, chemotherapy is considered a treatment of last resort for patients with resistance to more effective therapies (immunotherapies and targeted therapies) or in countries where access to new more‐effective drugs is limited\n3\n, \n63\n, \n108\n, \n114\n (Figure 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Moreover, the length of the linear hydrocarbon substituent at the C7 position of the A ring has a directly proportional effect on the antiproliferative activity (Figure 4).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "44\n, \n45\n This process is induced via complicated interactions between genetic and environmental factors such as UV radiation, genetic mutations, oncogene activation, malignancy suppressor gene deactivation, and DNA repair process disorder (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "4\n, \n5\n, \n46\n, \n47\n, \n48\n, \n49\n, \n50\n, \n51\n\n\nFigure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The genomic changes induce impairments to the activation of fundamental signaling pathways, namely, the PI3K pathway and the RAS/rapidly accelerated fibrosarcoma (RAF)/mitogen‐activated protein kinase (MEK)/extracellular‐regulated kinase (ERK) signaling cascade, also known as the MAPK pathway (Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "86\n, \n87\n, \n88\n, \n89\n\n\nFigure 2.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "31\n, \n97\n, \n104\n, \n105\n Both CDK4 and CDKN2A participate in the regulation of the cell cycle and regulate the transition of tumor cells from the G1 to S phase and thus can cause uncontrolled proliferation (Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Currently, chemotherapy is considered a treatment of last resort for patients with resistance to more effective therapies (immunotherapies and targeted therapies) or in countries where access to new more‐effective drugs is limited\n3\n, \n63\n, \n108\n, \n114\n (Figure 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Moreover, the length of the linear hydrocarbon substituent at the C7 position of the A ring has a directly proportional effect on the antiproliferative activity (Figure 4).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "44\n, \n45\n This process is induced via complicated interactions between genetic and environmental factors such as UV radiation, genetic mutations, oncogene activation, malignancy suppressor gene deactivation, and DNA repair process disorder (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "4\n, \n5\n, \n46\n, \n47\n, \n48\n, \n49\n, \n50\n, \n51\n\n\nFigure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The genomic changes induce impairments to the activation of fundamental signaling pathways, namely, the PI3K pathway and the RAS/rapidly accelerated fibrosarcoma (RAF)/mitogen‐activated protein kinase (MEK)/extracellular‐regulated kinase (ERK) signaling cascade, also known as the MAPK pathway (Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "86\n, \n87\n, \n88\n, \n89\n\n\nFigure 2.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "31\n, \n97\n, \n104\n, \n105\n Both CDK4 and CDKN2A participate in the regulation of the cell cycle and regulate the transition of tumor cells from the G1 to S phase and thus can cause uncontrolled proliferation (Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Currently, chemotherapy is considered a treatment of last resort for patients with resistance to more effective therapies (immunotherapies and targeted therapies) or in countries where access to new more‐effective drugs is limited\n3\n, \n63\n, \n108\n, \n114\n (Figure 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Moreover, the length of the linear hydrocarbon substituent at the C7 position of the A ring has a directly proportional effect on the antiproliferative activity (Figure 4).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "44\n, \n45\n This process is induced via complicated interactions between genetic and environmental factors such as UV radiation, genetic mutations, oncogene activation, malignancy suppressor gene deactivation, and DNA repair process disorder (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "4\n, \n5\n, \n46\n, \n47\n, \n48\n, \n49\n, \n50\n, \n51\n\n\nFigure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The genomic changes induce impairments to the activation of fundamental signaling pathways, namely, the PI3K pathway and the RAS/rapidly accelerated fibrosarcoma (RAF)/mitogen‐activated protein kinase (MEK)/extracellular‐regulated kinase (ERK) signaling cascade, also known as the MAPK pathway (Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "86\n, \n87\n, \n88\n, \n89\n\n\nFigure 2.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "31\n, \n97\n, \n104\n, \n105\n Both CDK4 and CDKN2A participate in the regulation of the cell cycle and regulate the transition of tumor cells from the G1 to S phase and thus can cause uncontrolled proliferation (Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Currently, chemotherapy is considered a treatment of last resort for patients with resistance to more effective therapies (immunotherapies and targeted therapies) or in countries where access to new more‐effective drugs is limited\n3\n, \n63\n, \n108\n, \n114\n (Figure 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Moreover, the length of the linear hydrocarbon substituent at the C7 position of the A ring has a directly proportional effect on the antiproliferative activity (Figure 4).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "44\n, \n45\n This process is induced via complicated interactions between genetic and environmental factors such as UV radiation, genetic mutations, oncogene activation, malignancy suppressor gene deactivation, and DNA repair process disorder (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "4\n, \n5\n, \n46\n, \n47\n, \n48\n, \n49\n, \n50\n, \n51\n\n\nFigure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "44\n, \n45\n This process is induced via complicated interactions between genetic and environmental factors such as UV radiation, genetic mutations, oncogene activation, malignancy suppressor gene deactivation, and DNA repair process disorder (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The genomic changes induce impairments to the activation of fundamental signaling pathways, namely, the PI3K pathway and the RAS/rapidly accelerated fibrosarcoma (RAF)/mitogen‐activated protein kinase (MEK)/extracellular‐regulated kinase (ERK) signaling cascade, also known as the MAPK pathway (Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "86\n, \n87\n, \n88\n, \n89\n\n\nFigure 2.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "31\n, \n97\n, \n104\n, \n105\n Both CDK4 and CDKN2A participate in the regulation of the cell cycle and regulate the transition of tumor cells from the G1 to S phase and thus can cause uncontrolled proliferation (Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The genomic changes induce impairments to the activation of fundamental signaling pathways, namely, the PI3K pathway and the RAS/rapidly accelerated fibrosarcoma (RAF)/mitogen‐activated protein kinase (MEK)/extracellular‐regulated kinase (ERK) signaling cascade, also known as the MAPK pathway (Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "86\n, \n87\n, \n88\n, \n89\n\n\nFigure 2.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The genomic changes induce impairments to the activation of fundamental signaling pathways, namely, the PI3K pathway and the RAS/rapidly accelerated fibrosarcoma (RAF)/mitogen‐activated protein kinase (MEK)/extracellular‐regulated kinase (ERK) signaling cascade, also known as the MAPK pathway (Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "31\n, \n97\n, \n104\n, \n105\n Both CDK4 and CDKN2A participate in the regulation of the cell cycle and regulate the transition of tumor cells from the G1 to S phase and thus can cause uncontrolled proliferation (Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "31\n, \n97\n, \n104\n, \n105\n Both CDK4 and CDKN2A participate in the regulation of the cell cycle and regulate the transition of tumor cells from the G1 to S phase and thus can cause uncontrolled proliferation (Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Currently, chemotherapy is considered a treatment of last resort for patients with resistance to more effective therapies (immunotherapies and targeted therapies) or in countries where access to new more‐effective drugs is limited\n3\n, \n63\n, \n108\n, \n114\n (Figure 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Currently, chemotherapy is considered a treatment of last resort for patients with resistance to more effective therapies (immunotherapies and targeted therapies) or in countries where access to new more‐effective drugs is limited\n3\n, \n63\n, \n108\n, \n114\n (Figure 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Currently, chemotherapy is considered a treatment of last resort for patients with resistance to more effective therapies (immunotherapies and targeted therapies) or in countries where access to new more‐effective drugs is limited\n3\n, \n63\n, \n108\n, \n114\n (Figure 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Moreover, the length of the linear hydrocarbon substituent at the C7 position of the A ring has a directly proportional effect on the antiproliferative activity (Figure 4).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Moreover, the length of the linear hydrocarbon substituent at the C7 position of the A ring has a directly proportional effect on the antiproliferative activity (Figure 4).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Moreover, the length of the linear hydrocarbon substituent at the C7 position of the A ring has a directly proportional effect on the antiproliferative activity (Figure 4).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  }
]